ABAMECTIN FOCUS MEETING AGENDA 	2/14/2013
Introductions
   
   1.    Goals of the Focus meeting
--ID areas of uncertainty which may affect risk assessment
--acquire information necessary to conduct a sound risk assessment

   2.    Registration Review Schedule
--abamectin docket opens _____________________
--PWP publication _______________________		
--FWP publication _______________________
--DCI expected to be issued ____________________

   3.    Brief overview of cheminova's, nufarm's, tide's, ensystex's, and celsius property's registrations (presented by each technical registrant in turn)
   
   
   
   4.    Overview of key uncertainties which may affect registration review (by EPA)
--label uncertainties -- 
      master label?
      Non-specified maximum use rates in the LUIS report
      
--data requirements
--HASPOC findings for subchronic inhalation tox study and subchronic dermal tox study


   5.    Other outstanding issues 
--current labels -- grape REI and new environmental hazards section with surface water text (RD)

   
   
   
   6.    Questions from abamectin registrants for EPA
